Sarcoma Growth Rate: Variable but Often Deceptively Slow
Sarcomas exhibit highly variable growth rates, and contrary to common assumptions, many highly malignant sarcomas can grow slowly—making them particularly dangerous because slow growth does not exclude aggressive behavior or high malignancy. The growth rate cannot be used to determine malignancy or prognosis 1, 2.
Key Clinical Insights
Growth Rate Characteristics
The evidence demonstrates that sarcoma growth rates are unpredictable and histology-dependent:
- Measured doubling time: Local recurrences show a geometric mean doubling time of approximately 14-15 days, which is actually faster than most human malignancies 3
- Clinical presentation: Despite aggressive biology, many highly malignant sarcomas present as slow-growing masses that can be present for 1-3 years before diagnosis, with some synovial sarcomas taking over 10 years to diagnose 1
- Natural growth: Untreated soft tissue sarcomas show an average growth of +39.4% in longest diameter and +503% in volume over approximately 130 days 2
Critical Clinical Pitfall
The most dangerous misconception is that slow-growing, painless masses—especially superficial ones—are benign. Multiple highly malignant sarcoma subtypes (synovial sarcoma, alveolar soft part sarcoma, clear cell sarcoma) characteristically present as slow-growing lesions 1. This leads to delayed diagnosis and inappropriate initial management.
Guideline-Based Approach to Suspicious Masses
Based on the most recent UK guidelines 4, any patient presenting with:
- Unexplained lump that is increasing in size → Direct access ultrasound within 2 weeks
- Deep mass of any size → Refer to specialist sarcoma MDT
- Superficial lesion >5 cm diameter → Refer to specialist sarcoma MDT 5, 6
Do not wait for rapid growth or pain to develop before referral. The absence of these features does not exclude high-grade malignancy.
Histology-Specific Patterns
Different subtypes show distinct growth characteristics:
- Synovial sarcoma: Often slow-growing, superficial, can be present for years 1
- Alveolar soft part sarcoma: Characteristically slow-growing with distinctive MRI features 1
- Liposarcoma/leiomyosarcoma: Variable growth rates
- High-grade undifferentiated sarcomas: Generally faster growing but still variable
The "Rapidly Growing" Myth
The concept of "rapidly growing leiomyoma" as a marker for uterine sarcoma is not supported by evidence—only 0.27% of patients operated for "rapidly growing" uterine masses had sarcoma 7. This reinforces that growth rate alone is an unreliable indicator.
Prognostic Implications
Growth rate measured on serial pre-treatment imaging does have prognostic value 2:
- Relative change in longest diameter per month independently predicts overall survival
- Absolute change in longest diameter per month independently predicts local recurrence-free survival
- Growth rate correlates with mitotic count, grade, and genomic complexity
However, this is useful for risk stratification after diagnosis, not for determining whether to biopsy a suspicious mass.
Bottom Line for Clinical Practice
Never reassure a patient based on slow growth alone. Any persistent soft tissue mass requires imaging evaluation, and any deep mass or superficial mass >5 cm requires specialist referral regardless of growth rate 4, 5. The biology of sarcomas is heterogeneous—some high-grade tumors grow slowly while maintaining their aggressive metastatic potential 1, 8.